Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 23Terminated 9Active not recruiting 6Unknown 3Recruiting 3No longer available 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Sarcoma 1

Conditions

Melanoma 2Sarcoma, Kaposi 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × talimogene laherparepvec × Clear all
NCT04065152 2022-06-10

KAPVEC

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown
20 enrolled
Sarcoma

Sarcoma, Kaposi

NCT03747744 2020-12-29

myDCTV

Universitair Ziekenhuis Brussel

Phase 1 Unknown
18 enrolled
Dermatologic

Melanoma

NCT03088176 2020-10-12

Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma

West Cancer Center

Phase 1 Unknown
4 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡